A recent study revealed that genetic variations in the lncRNAs HULC and MALAT1 are associated with decreased susceptibility to hepatocellular carcinoma (in persistent carriers of HBV), and these lncRNAs thus constitute two potential diagnostic biomarkers for hepatocellular carcinoma (Motawi et al., 2019). Here, HULC is linked to hepatocellular carcinoma.